retatrutide 2 mg ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial what is the max dose

Dean OM, Bush AI, Copolov DL, Kohlmann K, Jeavons S, Schapkaitz I, et al

Do not discontinue GLP-1 therapy without medical guidance, as night sweats are not an established side effect of these medications

The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain T reg cell activation and suppression of antitumor immunity

This is a survival mechanism

In the CNS, GLP-1Rs are expressed by neurons in the hippocampus, which is known to be a cognition-related brain region, and have been observed in neocortical pyramidal neurons (Hamilton and Holscher, 2009)

Dose escalation, starting weight, diet quality, and exercise level all impact timeline